SEOUL, Nov. 29 (Yonhap) -- Vitabon Co., a South Korean venture firm, said Friday it has launched a trademark infringement suit against tobacco giant British American Tobacco (BAT).
Vitabon claims that its nicotine-free aromatherapy device, named Sense, and BAT's hybrid e-cigarette product, glo sens, confuse consumers due to their similar names.
Vitabon said it has filed the lawsuit with the Seoul Central District Court, demanding 110 million won (US$93,000) in compensation and that manufacturing and sales of glo sens be banned in the country.
"Despite the fact that Vitabon Sense is a product designed to help customers quit smoking and glo sens is an e-cigarette product, the methods of use are very similar and their customer bases very close," a Vitabon official said. "Vitabon Sense was also released prior to glo sens."
BAT Korea said it plans to file a countersuit against Vitabon, saying that the names of the two products are not confusing to consumers at all.
Bumpy road lies ahead for Samsung, even after heir avoids detention
One month into eased social distancing, S. Korea wrestles with cluster infections, cases with unknown routes
Virus outbreak sheds light on overlooked side of highly touted 'fast' delivery services
Moon's post-corona presidency laden with tough tasks
S. Korea shifts toward new normal of everyday quarantine but wary of 'blind spots'